NVS antibody

DB05312ExperimentalSmall molecule

This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.

Primary indication
Investigated for use/treatment in autoimmune diseases and rheumatoid arthritis.Curator reviewed

Which companies are running trials of NVS antibody, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In